Cadila Healthcare’s manufacturing facility Alidac Pharmaceuticals Ltd. (Alidac), located at Pharmez, Ahmedabad, has received an establishment inspection report (EIR). The USFDA had conducted a pre-approval inspection (PAI) for doxorubicin liposomal,…Read More
Aurobindo Pharma Limited will invest up to USD 200 million on CapEx and over 5 percent of sale value on research and development (R&D) during the current financial year. The…Read More
India Alternatives Investment Advisors Ltd. has invested up to USD 8 million for a significant minority stake in Brinton Pharmaceuticals Limited. Among the fastest-growing companies in the Indian pharmaceutical market,…Read More
The board of Alembic Pharmaceuticals has approved raising of up to Rs 300 crore through issuance of non-convertible debentures (NCDs) on a private placement basis. The company will issue NCDs…Read More
Natco Pharma expects India, Brazil, and Canada markets to be its revenue drivers during the current financial year, recording growth of 30 percent to 40 percent. The India business alone…Read More
Lupin has initiated a nationwide voluntary recall of pneumonia antibiotic in the US after a complaint of metal piece in the bottle was received. In a recent enforcement report, the…Read More
GlaxoSmithKline (GSK) has secured approval from the US Food and Drug Administration (USFDA) for two new methods for administering Nucala (mepolizumab), an auto-injector and a pre-filled safety syringe. Nucala is…Read More
Novartis India has appointed Sanjay Murdeshwar as vice chairman and managing director of the company. Currently, he is Novartis’ country president in India and is responsible for the company’s pharmaceuticals…Read More
Merck Ltd. has been renamed as Procter & Gamble Health Ltd., following P&G’s global acquisition of the consumer health business of Merck KGaA, Germany. The company has received approval from…Read More
GlaxoSmithKline Pharmaceuticals has reported a 16.56 percent rise in its standalone net profit to Rs 123.03 crore for the quarter ended March 31, 2019. The company had posted a net…Read More
Despite the pressure of business in the US, pharma major, Lupin Limited, recorded a 5.2 percent rise in revenues to Rs 16,369.4 crore in FY19, as compared to Rs 15,559.8…Read More
Caplin Point Laboratories has received approval from Colombia’s drug regulatory body, The Colombia National Food and Drug Surveillance Institute (INVIMA), for its small-volume sterile injectable division at Puducherry. The inspection…Read More
Shilpa Medicare has received US Food and Drug Administration (USFDA) final approval for its ANDA, zoledronic acid injection, 4 mg/5 mL. Zoledronic acid injection, 4 mg/5 ml is a generic…Read More
Glenmark Pharmaceuticals has received final approval from the US health regulator for generic version of AstraZeneca’s Nexium, used to treat acid reflux. The company has been granted final approval by…Read More
Zydus Cadila has received final nod from the US health regulator to market Chlorthalidone tablets, used to treat high blood pressure. Zydus Cadila has received the final approval from the…Read More